Agilon Health (AGL)
(Delayed Data from NYSE)
$5.00 USD
-0.13 (-2.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.00 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AGL 5.00 -0.13(-2.53%)
Will AGL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGL
New Strong Sell Stocks for March 25th
New Strong Sell Stocks for March 15th
AGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for February 28th
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
Other News for AGL
Buy Rating Affirmed for Agree Realty on Strong Q1 Earnings, Conservative Growth Forecast, and Strategic Financial Positioning
CORRECT: No record close for FTSE 100; mixed trade in US
LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US
Angle shares jump on supplier agreement with with AstraZeneca
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook